Literature DB >> 19736015

Design, synthesis and structure-activity relationship of 2-(3',4',5'-trimethoxybenzoyl)-benzo[b]furan derivatives as a novel class of inhibitors of tubulin polymerization.

Romeo Romagnoli1, Pier Giovanni Baraldi, Maria Dora Carrion, Carlota Lopez Cara, Olga Cruz-Lopez, Manlio Tolomeo, Stefania Grimaudo, Antonietta Di Cristina, Maria Rosaria Pipitone, Jan Balzarini, Nicola Zonta, Andrea Brancale, Ernest Hamel.   

Abstract

The biological importance of microtubules in mitosis and cell division makes them an interesting target for the development of anticancer agents. Small molecules such as benzo[b]furans are attractive as inhibitors of tubulin polymerization. Thus, a new class of inhibitors of tubulin polymerization based on the 2-(3',4',5'-trimethoxybenzoyl)-benzo[b]furan molecular skeleton, with electron-donating (Me, OMe or OH) or electron-withdrawing (F, Cl and Br) substituents on the benzene ring, was synthesized and evaluated for antiproliferative activity, inhibition of tubulin polymerization and cell cycle effects. Adding a methyl group at the C-3 position resulted in increased activity. The most promising compound in this series was 2-(3',4',5'-trimethoxybenzoyl)-3-methyl-6-ethoxy-benzo[b]furan, which inhibits cancer cell growth at nanomolar concentrations and interacts strongly with tubulin by binding to the colchicine site.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19736015      PMCID: PMC2762272          DOI: 10.1016/j.bmc.2009.08.027

Source DB:  PubMed          Journal:  Bioorg Med Chem        ISSN: 0968-0896            Impact factor:   3.641


  32 in total

1.  Synthesis and structure-activity relationship of 2-aminobenzophenone derivatives as antimitotic agents.

Authors:  Jing-Ping Liou; Chun-Wei Chang; Jeng-Shin Song; Yung-Ning Yang; Ching-Fang Yeh; Huan-Yi Tseng; Yu-Kang Lo; Yi-Ling Chang; Chung-Ming Chang; Hsing-Pang Hsieh
Journal:  J Med Chem       Date:  2002-06-06       Impact factor: 7.446

Review 2.  Evaluation of antimitotic agents by quantitative comparisons of their effects on the polymerization of purified tubulin.

Authors:  Ernest Hamel
Journal:  Cell Biochem Biophys       Date:  2003       Impact factor: 2.194

Review 3.  Microtubules as a target for anticancer drugs.

Authors:  Mary Ann Jordan; Leslie Wilson
Journal:  Nat Rev Cancer       Date:  2004-04       Impact factor: 60.716

4.  Insight into tubulin regulation from a complex with colchicine and a stathmin-like domain.

Authors:  Raimond B G Ravelli; Benoît Gigant; Patrick A Curmi; Isabelle Jourdain; Sylvie Lachkar; André Sobel; Marcel Knossow
Journal:  Nature       Date:  2004-03-11       Impact factor: 49.962

Review 5.  Antimitotic chalcones and related compounds as inhibitors of tubulin assembly.

Authors:  Sylvie Ducki
Journal:  Anticancer Agents Med Chem       Date:  2009-03       Impact factor: 2.505

6.  Isolation and structure of the strong cell growth and tubulin inhibitor combretastatin A-4.

Authors:  G R Pettit; S B Singh; E Hamel; C M Lin; D S Alberts; D Garcia-Kendall
Journal:  Experientia       Date:  1989-02-15

7.  Potential therapeutic antioxidants that combine the radical scavenging ability of myricetin and the lipophilic chain of vitamin E to effectively inhibit microsomal lipid peroxidation.

Authors:  Christopher J Bennett; Stuart T Caldwell; Donald B McPhail; Philip C Morrice; Garry G Duthie; Richard C Hartley
Journal:  Bioorg Med Chem       Date:  2004-05-01       Impact factor: 3.641

Review 8.  Combretastatin A4 phosphate: background and current clinical status.

Authors:  Scott L Young; David J Chaplin
Journal:  Expert Opin Investig Drugs       Date:  2004-09       Impact factor: 6.206

Review 9.  Combretastatin A-4 analogues as antimitotic antitumor agents.

Authors:  Nguyen-Hai Nam
Journal:  Curr Med Chem       Date:  2003-09       Impact factor: 4.530

10.  Separation of active tubulin and microtubule-associated proteins by ultracentrifugation and isolation of a component causing the formation of microtubule bundles.

Authors:  E Hamel; C M Lin
Journal:  Biochemistry       Date:  1984-08-28       Impact factor: 3.162

View more
  11 in total

1.  Synthesis and antitumor activity of 1,5-disubstituted 1,2,4-triazoles as cis-restricted combretastatin analogues.

Authors:  Romeo Romagnoli; Pier Giovanni Baraldi; Olga Cruz-Lopez; Carlota Lopez Cara; Maria Dora Carrion; Andrea Brancale; Ernest Hamel; Longchuan Chen; Roberta Bortolozzi; Giuseppe Basso; Giampietro Viola
Journal:  J Med Chem       Date:  2010-05-27       Impact factor: 7.446

2.  Substituted 2-(3',4',5'-trimethoxybenzoyl)-benzo[b]thiophene derivatives as potent tubulin polymerization inhibitors.

Authors:  Romeo Romagnoli; Pier Giovanni Baraldi; Maria Dora Carrion; Olga Cruz-Lopez; Manlio Tolomeo; Stefania Grimaudo; Antonietta Di Cristina; Maria Rosaria Pipitone; Jan Balzarini; Andrea Brancale; Ernest Hamel
Journal:  Bioorg Med Chem       Date:  2010-06-01       Impact factor: 3.641

3.  Tubulin inhibitors: pharmacophore modeling, virtual screening and molecular docking.

Authors:  Miao-Miao Niu; Jing-Yi Qin; Cai-Ping Tian; Xia-Fei Yan; Feng-Gong Dong; Zheng-Qi Cheng; Guissi Fida; Man Yang; Hai-Yan Chen; Yue-Qing Gu
Journal:  Acta Pharmacol Sin       Date:  2014-06-09       Impact factor: 6.150

4.  A novel and facile synthesis of 3-(2-benzofuroyl)- and 3,6-bis(2-benzofuroyl)carbazole derivatives.

Authors:  Wentao Gao; Meiru Zheng; Yang Li
Journal:  Beilstein J Org Chem       Date:  2011-11-17       Impact factor: 2.883

5.  Synthesis of poly-functionalized benzofurans via one-pot domino oxidation/[3+2] cyclization reactions of a hydroquinone ester and ynamides.

Authors:  Dongxin Zhang; Jingjing Man; Yan Chen; Lei Yin; Junchao Zhong; Qian-Feng Zhang
Journal:  RSC Adv       Date:  2019-04-25       Impact factor: 4.036

6.  Design, Synthesis and Cytotoxicity Evaluationof New 1,2-diaryl-4, 5, 6, 7-Tetrahydro-1H-benzo[d] Imidazolesas Tubulin Inhibitors.

Authors:  Marzieh Amirmostofian; Farzad Kobarfard; Hamed Reihanfard; Vida Mashayekhi; Afshin Zarghi
Journal:  Iran J Pharm Res       Date:  2015       Impact factor: 1.696

7.  Cyclopropylmethyl Protection of Phenols: Total Synthesis of the Resveratrol Dimers Anigopreissin A and Resveratrol-Piceatannol Hybrid.

Authors:  Arvind Kumar; Michael Saleeb; Dominik Werz; Mikael Elofsson
Journal:  ChemistryOpen       Date:  2018-11-05       Impact factor: 2.911

8.  Synthesis, Evaluation for Cytotoxicity and Molecular Docking Studies of Benzo[c]furan-Chalcones for Potential to Inhibit Tubulin Polymerization and/or EGFR-Tyrosine Kinase Phosphorylation.

Authors:  Malose J Mphahlele; Marole M Maluleka; Nishal Parbhoo; Sibusiso T Malindisa
Journal:  Int J Mol Sci       Date:  2018-08-28       Impact factor: 5.923

9.  Tubulin Inhibitors: A Chemoinformatic Analysis Using Cell-Based Data.

Authors:  Edgar López-López; Carlos M Cerda-García-Rojas; José L Medina-Franco
Journal:  Molecules       Date:  2021-04-24       Impact factor: 4.411

10.  Development of novel benzofuran-isatin conjugates as potential antiproliferative agents with apoptosis inducing mechanism in Colon cancer.

Authors:  Wagdy M Eldehna; Rofaida Salem; Zainab M Elsayed; Tarfah Al-Warhi; Hamada R Knany; Rezk R Ayyad; Thamer Bin Traiki; Maha-Hamadien Abdulla; Rehan Ahmad; Hatem A Abdel-Aziz; Radwan El-Haggar
Journal:  J Enzyme Inhib Med Chem       Date:  2021-12       Impact factor: 5.051

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.